Pfizer
-
COVID-19 Medication Paxlovid's Price Expected to Rise in 2024
-
FDA Approves New Pfizer and Moderna COVID-19 Vaccines Targeting Omicron Variant XBB.1.5
-
FDA Approves Another COVID-19 Booster Vaccine for 65 Years and Older—When is it Available?
-
Pfizer's Fast-Acting Nasal Spray for Migraine Treatment Gets Approval From the US FDA
-
UK Watchdog Deems Pfizer CEO Albert Bourla's Statements on Kids' Covid Vaccines 'Misleading'
-
Pfizer Pours in Almost $120 million for App that Detects Covid from Cough
-
Pfizer-BioNTech Seeks Emergency Use of Covid Booster for Children Aged 5-11
-
Pfizer and Moderna Vaccines Against Omicron Variant Approved by the FDA
-
Moderna Sues Pfizer, BioNTech for Use of mRNA Technology in COVID Vaccines—Pfizer Responds
-
Pfizer to Bring COVID-19 Omicron Booster Shots this Fall—Is It Still a Need?
-
Modified Pfizer Omicron-Based Vaccine Boosts Defense Against Variant? FDA To Discuss Tweaked COVID-19 Medicine
-
Pfizer Found Effective in Children Under 5, Experts to Make Recommendations This Week
Most Popular
